Ccme Global Limited
BSE: GENESIS · Biotechnology
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Ccme Global Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Genesis IBRC India Limited is a public limited company primarily engaged in the manufacturing and trading of industrial rubber products and components. The firm has diversified its operations to include financial activities and investments to leverage emerging market opportunities within India.
Business Model
The company generates revenue through the production and supply of industrial rubber goods alongside strategic financial investments. It operates as a small-cap entity focused on niche industrial supply chain requirements.
Management Commentary
Management is currently focused on streamlining manufacturing processes while exploring strategic growth opportunities within the broader industrial landscape.
Growth Outlook
Growth is expected to be driven by the company's efforts to enhance operational efficiency and its continued participation in the domestic industrial supply chain.
Key Risks
- Market Volatility. As a small-cap entity, the company is susceptible to significant fluctuations in market valuation and liquidity.
- Operational Concentration. Reliance on niche industrial rubber markets may limit revenue scalability and expose the firm to sector-specific downturns.
- Regulatory and Economic Risk. Changes in industrial policies or broader economic conditions in India could adversely impact manufacturing and investment activities.
Start your research today
Unlock AI insights, financials, peers and live data on Ccme Global Limited and 5,000+ companies — free.
Key Metrics
NET PROFIT
₹4 Cr
TTM · standalone
EPS
₹2.72
TTM · standalone
RETURN ON EQUITY
63.7%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
62.8%
TTM · standalone
P/E
32.9x
Q1 FY26 · standalone
EV/EBITDA
34.8x
Q1 FY26 · standalone
DEBT TO EQUITY
0.0x
Q2 FY26 · standalone
Peers · Biotechnology
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Ccme Global LimitedGENESIS | ₹180 Cr | 32.95 | 47.84 | — | -80.0% | 63.7% | 62.8% | +4.5% |
Anthem Biosciences Ltd.ANTHEM | ₹50,693 Cr | 131.02 | 53.09 | — | 47.5% | 18.9% | 25.4% | +10.0% |
Advanced Enzyme Technologies LimitedADVENZYMES | ₹3,357 Cr | 20.23 | 12.45 | 12.2% | 35.0% | 11.3% | 14.3% | -13.3% |
As of Q1 FY26
Financials
Ccme Global Limited
BSE: GENESIS · Biotechnology
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Ccme Global Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Genesis IBRC India Limited is a public limited company primarily engaged in the manufacturing and trading of industrial rubber products and components. The firm has diversified its operations to include financial activities and investments to leverage emerging market opportunities within India.
Business Model
The company generates revenue through the production and supply of industrial rubber goods alongside strategic financial investments. It operates as a small-cap entity focused on niche industrial supply chain requirements.
Management Commentary
Management is currently focused on streamlining manufacturing processes while exploring strategic growth opportunities within the broader industrial landscape.
Growth Outlook
Growth is expected to be driven by the company's efforts to enhance operational efficiency and its continued participation in the domestic industrial supply chain.
Key Risks
- Market Volatility. As a small-cap entity, the company is susceptible to significant fluctuations in market valuation and liquidity.
- Operational Concentration. Reliance on niche industrial rubber markets may limit revenue scalability and expose the firm to sector-specific downturns.
- Regulatory and Economic Risk. Changes in industrial policies or broader economic conditions in India could adversely impact manufacturing and investment activities.
Start your research today
Unlock AI insights, financials, peers and live data on Ccme Global Limited and 5,000+ companies — free.
Key Metrics
NET PROFIT
₹4 Cr
TTM · standalone
EPS
₹2.72
TTM · standalone
RETURN ON EQUITY
63.7%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
62.8%
TTM · standalone
P/E
32.9x
Q1 FY26 · standalone
EV/EBITDA
34.8x
Q1 FY26 · standalone
DEBT TO EQUITY
0.0x
Q2 FY26 · standalone
Peers · Biotechnology
As of Q1 FY26